Canopy Growth Corporation Share Price

Equities

WEED

CA1380357048

Pharmaceuticals

Delayed Toronto S.E. 19:58:37 18/06/2024 BST 5-day change 1st Jan Change
9.74 CAD -2.31% Intraday chart for Canopy Growth Corporation -3.28% +44.08%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2025 * 303M 221M 17.38B Sales 2026 * 324M 236M 18.58B Capitalization 760M 554M 43.59B
Net income 2025 * -138M -101M -7.92B Net income 2026 * -104M -75.82M -5.97B EV / Sales 2025 * 3.94 x
Net Debt 2025 * 434M 317M 24.92B Net Debt 2026 * 517M 377M 29.66B EV / Sales 2026 * 3.94 x
P/E ratio 2025 *
-6.59 x
P/E ratio 2026 *
-9.2 x
Employees 1,029
Yield 2025 *
-
Yield 2026 *
-
Free-Float 99.66%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.31%
1 week-3.28%
Current month-15.96%
1 month-29.47%
3 months+93.64%
6 months+47.58%
Current year+44.08%
More quotes
1 week
9.56
Extreme 9.56
10.61
1 month
9.34
Extreme 9.34
14.63
Current year
3.74
Extreme 3.74
20.50
1 year
3.74
Extreme 3.74
26.00
3 years
3.74
Extreme 3.74
315.60
5 years
3.74
Extreme 3.74
716.00
10 years
3.74
Extreme 3.74
766.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 31/10/18
Director of Finance/CFO 52 01/12/19
Investor Relations Contact - 31/12/15
Members of the board TitleAgeSince
Chief Executive Officer 60 31/10/18
Chairman 69 30/03/20
Director/Board Member 67 30/03/20
More insiders
Date Price Change Volume
18/06/24 9.74 -2.31% 452 718
17/06/24 9.97 -0.20% 752,223
14/06/24 9.99 -2.82% 637,681
13/06/24 10.28 -1.44% 565,315
12/06/24 10.43 +3.57% 1,616,322

Delayed Quote Toronto S.E., June 18, 2024 at 07:58 pm

More quotes
Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
14
Last Close Price
9.97 CAD
Average target price
8.975 CAD
Spread / Average Target
-9.98%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW